Eli Lilly is reported to be axing millions of dollars ... says that the pharma group had suspended all Twitter ad campaigns very soon after the imposter accounts started to appear, and even ...

Eli Lilly, on the verge of the first consumer ad campaign for its Zepbound weight loss drug, has helped the Obesity Action ...

So far this year, Eli Lilly (NYSE: LLY) has been on an absolute tear and is swiftly becoming the world's most prolific ...

Eli Lilly (LLY) is planning to advertise its blockbuster weight loss drug, Zepbound, for the first time next month. Despite investor and industry recognition of the branded GLP-1 drug, "unaided ...

Conditions are getting a bit more challenging for the drugmaker.

Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot causes excessive bone mineral ...

AP Health Writer (AP) — Eli Lilly is dialing back its 2024 forecast after underwhelming ... Advertisement Article continues below this ad The company brought in $3.1 billion in sales from Mounjaro and ...

Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to ...

What would a Harris or Trump presidency mean for health care policy? Why did Eli Lilly’s Mounjaro and Zepbound sales miss expectations? And does Adam believe in ghosts? We talk about all that an ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor ...

The S&P 500 slipped 0.3 percent after drifting between small gains and losses several times, though it's still near its ...